- Jan 26, 2021
Modified version of CAR T-cell therapy shows promise in targeting neuroblastoma
Now, a group of scientists at Children's Hospital Los Angeles have developed a modified version of CAR T that shows promise in targeting...
- Jan 25, 2021
Landmark research toward increasing survival rates for aggressive childhood cancer
A new combination of drugs could help to increase survival rates with fewer side effects for some children with one of the most...
- Jan 22, 2021
FDA Approves Crizotinib for Pediatric ALK+ ALCL Indication
Crizotinib—a tyrosine kinase inhibitor with activity against ALK, ROS1, and MET—was granted FDA approval for use in pediatric patients ...
- Jan 7, 2021
Drug combination increases susceptibility to chemotherapy in cases of severe neuroblastoma
Researchers at the University of Gothenburg now suggest a possible cure for children with hard-to-treat forms of neuroblastoma using a...
- Jan 6, 2021
Fermanagh scientist leads breakthrough on childhood cancer research
A scientist from Kinawely now based in Amsterdam has led a breakthrough discovery in childhood cancer research. Dr. Caitrín Crudden is a...
- Jan 5, 2021
Parents' finances differently affected by having a child diagnosed with cancer
Mothers and fathers of children diagnosed with cancer are affected financially in different ways. While mothers' incomes fall in the...